{"id":"https://openalex.org/W7146420716","doi":null,"title":"Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity","display_name":"Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity","alternate_titles":[],"publication_year":2025,"publication_date":"2025-09-26","ids":{"openalex":"https://openalex.org/W7146420716"},"language":"en","primary_location":{"id":"pmh:oai:irdb.nii.ac.jp:00976:0007135171","doi":null,"is_oa":true,"landing_page_url":"https://showa.repo.nii.ac.jp/records/2000539","pdf_url":"https://showa.repo.nii.ac.jp/record/2000539/files/ko3618_fulltext.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"doctoral thesis"},"parent_works":[],"lineage":["https://openalex.org/W7146420716"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://showa.repo.nii.ac.jp/record/2000539/files/ko3618_fulltext.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056543912","display_name":"Yoichiro Narikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119182057","display_name":"SHOWA Medical University","ror":"https://ror.org/04mzk4q39","country_code":"JP","type":"education","lineage":["https://openalex.org/I119182057"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"\u6210\u5ddd, \u967d\u4e00\u90ce","raw_affiliation_strings":["\u662d\u548c\u533b\u79d1\u5927\u5b66 / Showa Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u662d\u548c\u533b\u79d1\u5927\u5b66 / Showa Medical University","institution_ids":["https://openalex.org/I119182057"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5056543912"],"corresponding_institution_ids":["https://openalex.org/I119182057"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inosine","display_name":"inosine","score":1.0},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9039999842643738},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.9179999828338623},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/adenosine-a2a-receptor","display_name":"adenosine A2A receptor","score":0.8700000047683716},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7440000176429749},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.8970000147819519},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.9200000166893005},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7919999957084656},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7960000038146973},{"id":"https://openalex.org/keywords/bacterial-metabolites","display_name":"bacterial metabolites","score":0.6140000224113464},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.37400001287460327}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6559000015258789},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5834000110626221},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5105999708175659},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.4271000027656555},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.396699994802475},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3865000009536743},{"id":"https://openalex.org/C2777610669","wikidata":"https://www.wikidata.org/wiki/Q422564","display_name":"Inosine","level":3,"score":0.3790000081062317},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.3743000030517578},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3741999864578247},{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.3619000017642975},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30169999599456787},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29739999771118164},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.2906999886035919},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2786000072956085},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2775999903678894},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.2662999927997589},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.25519999861717224},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2531000077724457},{"id":"https://openalex.org/C3017875465","wikidata":"https://www.wikidata.org/wiki/Q189146","display_name":"Cellular immunity","level":3,"score":0.25220000743865967}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:irdb.nii.ac.jp:00976:0007135171","doi":null,"is_oa":true,"landing_page_url":"https://showa.repo.nii.ac.jp/records/2000539","pdf_url":"https://showa.repo.nii.ac.jp/record/2000539/files/ko3618_fulltext.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"doctoral thesis"}],"best_oa_location":{"id":"pmh:oai:irdb.nii.ac.jp:00976:0007135171","doi":null,"is_oa":true,"landing_page_url":"https://showa.repo.nii.ac.jp/records/2000539","pdf_url":"https://showa.repo.nii.ac.jp/record/2000539/files/ko3618_fulltext.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"doctoral thesis"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7146420716.pdf","grobid_xml":"https://content.openalex.org/works/W7146420716.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W2003635153","https://openalex.org/W2165456770","https://openalex.org/W2185075416","https://openalex.org/W2277413600","https://openalex.org/W2766903152","https://openalex.org/W2794323030","https://openalex.org/W2801309958","https://openalex.org/W2915010259","https://openalex.org/W3016607029","https://openalex.org/W3022450273","https://openalex.org/W3027658010","https://openalex.org/W3034524707","https://openalex.org/W3049052172","https://openalex.org/W3106005610","https://openalex.org/W3108853735","https://openalex.org/W4210377299","https://openalex.org/W4226017477","https://openalex.org/W4296038319","https://openalex.org/W4323314878","https://openalex.org/W4391234755","https://openalex.org/W4397022927","https://openalex.org/W4402525709"],"related_works":["https://openalex.org/W4402525709","https://openalex.org/W2160141570","https://openalex.org/W2745455975","https://openalex.org/W7204456338","https://openalex.org/W4384200627","https://openalex.org/W2971123698","https://openalex.org/W7165551082","https://openalex.org/W7132814617","https://openalex.org/W3080134434","https://openalex.org/W4313829789"],"abstract_inverted_index":{"Inosine,":[0],"a":[1,66,172],"bacterial":[2],"metabolite":[3],"and":[4,43,76,94,98,113,153,170],"agonist":[5],"of":[6,30,35,104,148],"the":[7,28,33,84,102,110,146],"adenosine":[8],"A2A":[9],"receptor,":[10],"modulates":[11],"antitumor":[12,111,144,158],"immunity.However,":[13],"its":[14],"precise":[15],"effects":[16],"on":[17,32],"immune":[18],"checkpoint":[19],"inhibitors":[20],"(ICIs)":[21],"remain":[22],"unclear.This":[23],"study":[24],"aimed":[25],"to":[26,46,126,175],"evaluate":[27],"impact":[29],"inosine":[31,56,71,105,149,163],"efficacy":[34],"anti-programmed":[36],"cell":[37,60],"death":[38],"protein":[39,117],"1":[40],"(PD-1)":[41],"therapy":[42,108,169],"explore":[44],"strategies":[45],"counteract":[47],"any":[48],"potential":[49],"inhibitory":[50,133],"effects.In":[51],"in":[52,83,121],"vitro":[53],"co-culture":[54],"systems,":[55],"selectively":[57],"suppressed":[58],"cancer":[59],"growth":[61,75],"without":[62],"impairing":[63],"T-cell":[64,100],"viability.In":[65],"murine":[67],"subcutaneous":[68],"tumor":[69,74,85],"model,":[70],"treatment":[72],"reduced":[73],"was":[77],"associated":[78],"with":[79,88,106,150,166],"elevated":[80],"interferongamma":[81],"levels":[82,127],"microenvironment,":[86],"along":[87],"increased":[89,114],"infiltration":[90],"by":[91],"tumor-infiltrating":[92],"lymphocytes":[93],"enhanced":[95,157],"splenic":[96,122],"CD4\u207a":[97],"CD8\u207a":[99],"frequencies.However,":[101],"combination":[103,147],"anti-PD-1":[107,129,152],"attenuated":[109],"effect":[112],"cytotoxic":[115],"T-lymphocyteassociated":[116],"4":[118],"(CTLA-4)":[119],"expression":[120],"T":[123],"cells":[124],"compared":[125],"after":[128],"monotherapy.To":[130],"overcome":[131],"this":[132],"effect,":[134],"we":[135],"tested":[136],"whether":[137],"adding":[138],"an":[139],"anti-CTLA-4":[140,154],"antibody":[141],"could":[142],"restore":[143],"immunity.Notably,":[145],"both":[151],"antibodies":[155],"significantly":[156],"efficacy.These":[159],"findings":[160],"suggest":[161],"that":[162],"may":[164],"synergize":[165],"dual":[167],"ICI":[168],"represent":[171],"promising":[173],"adjunct":[174],"improve":[176],"immunotherapeutic":[177],"outcomes.":[178]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7146420716","counts_by_year":[],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2026-04-01T00:00:00"}
